India has approved Gilead Sciences Inc’s antiviral drug remdesivir for emergency use for five doses in treating Covid-19 patients.
Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in Covid-19 patients in formal clinical trials and is at the forefront of the battle against Covid-19, which has no approved treatment or vaccine.
“(Remdesivir) approved on June 1 under emergency use with condition for five dose administration,” the Drugs Controller General of India said in an email on Tuesday.
The drug was granted emergency use authorization by the US Food and Drug Administration last month and has received approval by Japanese health regulators.
Source : News 18